Tag: persistent atrial fibrillation
RHYTHM AI to collaborate with Biosense Webster on STAR Mapping clinical...
RHYTHM AI has announced the signing of a research collaboration agreement with Biosense Webster. A press release from RHYTHM AI outlines that the agreement...
Persistent atrial fibrillation—seeking the sources of the cardiac electrical field
Andrew Grace charts the evolution of non-contact mapping culminating in the current AcQMap system—the technology has advanced understanding of persistent atrial fibrillation (AF), providing...
JACC retracts OASIS trial paper
The Journal of the American College of Cardiology (JACC) has retracted the paper titled: “Impact of rotor ablation in non-paroxysmal atrial fibrillation patients: Results...
The OASIS trial: A critical appraisal
Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...
First randomised trial shows “poor outcomes” with rotor ablation
OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...
Non-invasive mapping prior to ablation may be an effective strategy for...
Preliminary data from the AFACART study have shown encouraging results when treating persistent atrial fibrillation with non-invasive mapping followed by pulmonary vein isolation and/or linear lesions.
Ablation of persistent atrial fibrillation, are we there yet?
Mark Earley (London, UK) argues that despite the breathtaking progress of interventional electrophysiology in the last 10 years, ablation of persistent atrial fibrillation remains an unconquered summit.